Seeing Is Believing
Momenta Pharmaceuticals's activity chart (see below) currently has 87 price targets and 64 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.09% with an average time for these price targets to be met of 234.32 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 30-Nov-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Aug-2020
$50
5 years 10 months 18 days ago
(25-Aug-2020)
10/10 (100%)
$19.95 (66.39%)
197
Hold Since 24-Aug-2020
$45
5 years 10 months 19 days ago
(24-Aug-2020)
7/7 (100%)
$20.74 (85.49%)
287
Hold Since 07-Nov-2018
$52.5
$0.02 (0.04%)
$38
5 years 10 months 23 days ago
(20-Aug-2020)
3/4 (75%)
$0.39 (0.75%)
124
Buy Since 13-Sep-2018
$47
5 years 10 months 23 days ago
(20-Aug-2020)
4/4 (100%)
$18.45 (64.62%)
379
Buy Since 06-Nov-2019
$48
5 years 10 months 24 days ago
(19-Aug-2020)
2/2 (100%)
$12.35 (34.64%)
85
What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?